Gene · 6335
Papers3,231
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 3,231
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Frontiers in Acute Pain Management: Emerging Concepts in Pain Pathways and the Role of VX-548 as a Novel NaV1.8 Inhibitor: A Narrative Review. | Curr Pain Headache Rep | 2024 | 38963514 | PubTator, text mining | PubMed |
| Carbamazepine in osteoarthritis treatment: A novel approach targeting Nav1.7 channels. | World J Orthop | 2024 | 38947258 | PubTator, text mining | PubMed |
| [Nav1.7 as a target for the first disease-modifying drugs for osteoarthritis]. | Nihon Yakurigaku Zasshi | 2024 | 38945912 | PubTator, text mining | PubMed |
| Deciphering the molecular landscape of human peripheral nerves: implications for diabetic peripheral neuropathy. | bioRxiv | 2024 | 38915676 | PubTator, text mining | PubMed |
| Regulating neuronal excitability: The role of S-palmitoylation in NaV1.7 activity and voltage sensitivity. | PNAS Nexus | 2024 | 38894876 | PubTator, text mining | PubMed |
| Carbenoid-involved reactions integrated with scaffold-based screening generates a Nav1.7 inhibitor. | Commun Chem | 2024 | 38866907 | PubTator, text mining | PubMed |
| Nanomedicine and voltage-gated sodium channel blockers in pain management: a game changer or a lost cause? | Drug Deliv Transl Res | 2024 | 38861139 | PubTator, text mining | PubMed |
| Action potentials in postganglionic sympathetic nerves depend on NaV1.7. | J Physiol | 2024 | 38805185 | PubTator, text mining | PubMed |
| Unique electrophysiological property of a novel Nav1.7, Nav1.8, and Nav1.9 sodium channel blocker, ANP-230. | Biochem Biophys Res Commun | 2024 | 38776832 | PubTator, text mining | PubMed |
| The road to evolution of ProTx2: how to be a subtype-specific inhibition of human Nav1.7. | Front Pharmacol | 2024 | 38756380 | PubTator, text mining | PubMed |
| Single-Cell Transcriptomic Analysis of Kaposi Sarcoma. | bioRxiv | 2024 | 38746135 | PubTator, text mining | PubMed |
| Role of NaV1.7 in postganglionic sympathetic nerve function in human and guinea-pig arteries. | J Physiol | 2024 | 38743485 | PubTator, text mining | PubMed |
| Molecular characterization of positively selected genes contributing aquatic adaptation in marine mammals. | Genes Genomics | 2024 | 38733518 | PubTator, text mining | PubMed |
| Peripherally targeted analgesia via AAV-mediated sensory neuron-specific inhibition of multiple pronociceptive sodium channels. | J Clin Invest | 2024 | 38722683 | PubTator, text mining | PubMed |
| Inhibiting Nav1.7 channels in pulpitis: An in vivo study on neuronal hyperexcitability. | Biochem Biophys Res Commun | 2024 | 38718567 | PubTator, text mining | PubMed |
| ST-2560, a selective inhibitor of the NaV1.7 sodium channel, affects nocifensive and cardiovascular reflexes in non-human primates. | Br J Pharmacol | 2024 | 38715413 | PubTator, text mining | PubMed |
| Similar excitability through different sodium channels and implications for the analgesic efficacy of selective drugs. | Elife | 2024 | 38687187 | PubTator, text mining | PubMed |
| A novel isoquinoline alkaloid HJ-69 isolated from Zanthoxylum bungeanum attenuates inflammatory pain by inhibiting voltage-gated sodium and potassium channels. | J Ethnopharmacol | 2024 | 38677570 | PubTator, text mining | PubMed |
| Editorial: Structural and functional venomics as a powerful approach for drug discovery and development. | Front Pharmacol | 2024 | 38659589 | PubTator, text mining | PubMed |
| Analgesic effect of Botulinum toxin in neuropathic pain is sodium channel independent. | Neuropharmacology | 2024 | 38657946 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6335/papers?page=13